US2022168356A1PendingUtilityA1
Allografts containing viable cells and methods therof
Est. expiryJan 3, 2038(~11.5 yrs left)· nominal 20-yr term from priority
A61K 38/39A01N 1/125A61L 2300/412A61K 9/0024A61L 2430/02A61L 2400/18A61L 27/3821A61K 35/32A61L 27/3612A61L 27/3658A61K 35/51A61K 31/728A61K 35/33A61L 27/3604A61L 2400/06A61L 27/3687A61L 2430/38A01N 1/0221
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Allograft biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting cartilage, tissue, bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. For example, the allograft may include viable cells, for example, which were native to intervertebral discs and/or umbilical cords that the allograft was derived from.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preparing an implantable composition for aiding tissue regeneration, the method comprising:
obtaining intervertebral disc from a human subject; washing the intervertebral disc with a phosphate buffered saline solution containing antibiotics; and milling the intervertebral disc into particles to form the implantable composition.
2 . The method of claim 1 , further comprising rinsing the particles with saline.
3 . The method of claim 1 , further comprising combining the particles with a cryoprotectant to form a mixture, and freezing the mixture at a temperature of from −80° C. to −180° C.
4 . The method of claim 3 , further comprising thawing the mixture and decanting the cryoprotectant before use.
5 . The method of claim 1 , further comprising combining the particles with a carrier solution containing one or more of hyaluronic acid (HA), collagen, aggrecan, chondroitin sulfate, and polyethylene glycol (PEG).
6 . The method of claim 1 , further comprising culturing the particles in a medium to obtain particles with proliferated cells.
7 . The method of claim 1 , further comprising treating the particles with an enzyme.
8 . A method of promoting bone or treating degenerated disc in a mammal, the method comprising:
providing a composition of allograft particles derived from human intervertebral disc comprising native collagen, native proteoglycan, and native viable cells; and administering the composition into a target repair site to facilitate repair or regeneration of tissue at the target repair site.
9 . The method of claim 8 , wherein the target repair site is an injury or defect in the spine and the tissue being regenerated is disc or bone.
10 . The method of claim 8 , wherein the native viable cells comprise chondrocytic cells, notochordal cells, nucleus pulposus stem/progenitor cells, fibrocytic cells, or a combination thereof.
11 . The method of claim 81 , wherein the native collagen includes collagen I, collagen II, or both.
12 . The method of claim 8 , wherein the intervertebral disc includes nucleus pulposus, annulus fibrosus, or both.
13 . The method of claim 8 , wherein the particles have a particle size ranging from about 250 microns to about 3 mm.
14 . The method of claim 8 , further comprising a cryoprotectant.
15 . The method of claim 8 , further comprising a carrier solution.
16 . The method of claim 15 , wherein the carrier solution includes one or more of hyaluronic acid (HA), collagen, aggrecan, chondroitin sulfate, and polyethylene glycol (PEG).Join the waitlist — get patent alerts
Track US2022168356A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.